Abstract

Dear Editor,
We are grateful for the interest in our article, 1 and we agree with much of what Mercadante are say. 2 We do not claim that IDDS results in improved survival. The article speaks only of the possibility of an association, and we are clear that we cannot infer causality from these results. Nevertheless, it is at least biologically plausible that effective pain relief in these patients could result in improved survival. We have also found that patients who successfully receive IDDS subsequently spend a greater proportion of their remaining days in the community setting. 3 Whilst both papers suffer from biases due to deficits of retrospective data, we feel that they tell an interesting story that requires further investigation. We acknowledge the need for investments to develop large-scale prospective registries, in order that more robust analyses can be performed to better inform the treatment options for a patient group in great need of support.
We completely agree that IDDS is an effective treatment modality for a select number of patients and that it is best considered as part of a multi-professional team. The service where this study was conducted is led by Palliative Care physicians and allows for comprehensive assessment and consideration of all available treatments to enable appropriate patient selection.
Footnotes
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
